Mark Blick
About
In The Last Decade
Mark Blick
55 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 1.0k
- Oncology 999
- Hematology 830
- Genetics 589
- Cancer Research 386
Countries citing papers authored by Mark Blick
This map shows the geographic impact of Mark Blick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Blick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Blick more than expected).
Fields of papers citing papers by Mark Blick
This network shows the impact of papers produced by Mark Blick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Blick. The network helps show where Mark Blick may publish in the future.
Co-authorship network of co-authors of Mark Blick
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Blick. A scholar is included among the top collaborators of Mark Blick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Blick. Mark Blick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | 145 | |
| 3 | Tumor necrosis factor and c-fos expression in human peripheral-blood monocytes: expression is dependent on stage of in vitro differentiation. | 1 |
| 4 | 101 | |
| 5 | 4 | |
| 6 | 23 | |
| 7 | c-erbB-2 amplification in node-negative human breast cancer. | 105 |
| 8 | 5 | |
| 9 | 35 | |
| 10 | 159 | |
| 11 | Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemia. | 11 |
| 12 | 94 | |
| 13 | 38 | |
| 14 | 67 | |
| 15 | 184 | |
| 16 | 27 | |
| 17 | 5 | |
| 18 | 7 | |
| 19 | Clonal nature of Philadelphia chromosome-positive and -negative chronic myelogenous leukemia by DNA hybridization analyses. | 11 |
| 20 | Development of a second Philadelphia (Ph1) chromosome in chronic myelogenous leukemia (CML) is characterized by a single aberrant overexpressed 8 kb c-abl transcript and the loss of the normal c-abl transcripts | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.